Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Neurointervention ; : 232-239, 2021.
Article in English | WPRIM | ID: wpr-918605

ABSTRACT

Purpose@#The treatment of aneurysms with characteristics such as complex morphology, fusiform, blister-like, wide neck, or large size has been revolutionized with the introduction of flow diverters. Though flow diverters have several advantages over coiling, they also have certain important disadvantages such as the lack of immediate protection against rupture, the risk of ischemic stroke, the need for antiplatelet therapy, and long latency for complete effect. The Derivo Embolization Device (DED) is a second-generation self-expanding device that is claimed to be less thrombogenic than conventional devices. We retrospectively evaluated the periprocedural safety and risks associated with the DED across 5 centers in India. @*Materials and Methods@#This is a multicentric, retrospective, observational study of DED, conducted at 5 high volume endovascular therapy centers in India from May 2018 to June 2020. Periprocedural demographic, clinical, and angiographic data were collected from a retrospective review of patient charts. @*Results@#A total of 96 patients, including 56 (58.3%) females, aged between 16–80 years (60±12.7 years) harboring 106 aneurysms were studied. Seven (7.3%) were noted to harbor multiple aneurysms: 6 had 3 aneurysms each, while 1 patient had 5 aneurysms. The following aneurysm characteristics were noted: average size, 9.8±8.2 mm; average neck size, 6.9±8.5 mm; wide-necked (>4 mm), 63 (59.4%); giant (>25 mm), 8 (7.5%); and anterior circulation location, 98 (92.5%). Eighteen (17%) of these were ruptured. Additional balloon angioplasty was performed in 5 (5.2%) patients. Intraprocedural problems were encountered in 3 (3.1%), of which only 1 had clinical implications, the device fish-mouthing with stent thrombosis resulting in a malignant middle cerebral artery territory infarction. The modified Rankin scale at 3 months was worse in 1 patient. @*Conclusion@#DED is a newer generation flow diverter stent with a low periprocedural complication rate.

2.
KMJ-Kuwait Medical Journal. 2015; 47 (2): 153-154
in English | IMEMR | ID: emr-171582

ABSTRACT

Foreign-body ingestion is relatively common in the pediatric population and most objects pass through the gastrointestinal tract with minimal complications. Swallowing more than one magnet is not uncommon worldwide and it frequently leads to serious consequences. We report a case of a 4-year-old boy who had accidentally swallowed two magnets which were passed spontaneously without any sequelae


Subject(s)
Humans , Male , Child, Preschool , Foreign Bodies , Deglutition
3.
KMJ-Kuwait Medical Journal. 2015; 47 (1): 52-53
in English | IMEMR | ID: emr-161687

ABSTRACT

Canaliform genitoperineal raphe cyst is an unusual entity. satisfactory recovery. Microbiology of cyst fluid confirmed A three-month-old infant presented with a cordlike white bacteroides infection. Management and clinical presentation swelling of one week duration. Surgical excision resulted in is discussed along with review of literature

4.
SJA-Saudi Journal of Anaesthesia. 2012; 6 (4): 358-362
in English | IMEMR | ID: emr-160460

ABSTRACT

It has been postulated that Multiple sclerosis [MS] stems from a narrowing in the veins that drain blood from the brain, known medically as chronic cerebrospinal venous insufficiency, or CCSVI. It has been proposed that balloon angioplasty should alleviate the symptoms of MS. This procedure is also known as "The Liberation Procedure." Accordingly, a clinical study was undertaken to determine the effects of dexmedetomidine in patients undergoing the liberation procedure. To assess the effectiveness of dexmedetomidine in providing adequate sedation and pain relief for patients undergoing the liberation procedure. Settings and A prospective, nonrandomized observational study of 60 consecutive adult patients undergoing the liberation procedure under monitored anesthesia care [MAC] who will receive dexmedetomidine as an anesthetic agent. A total of 60 adult patients were enrolled in the study. Dexmedetomidine was administered to all patients in a loading dose of 1 mcg/kg, which was followed by a maintenance dose of 0.2-0.5 mcg/kg/h. The evaluation of quality of sedation was based on Ramsay Sedation and the quality of analgesia was assessed using the visual analog scale. The following parameters were measured continuously: heart rate, mean arterial pressure and hemoglobin oxygen saturation. Patients were asked to answer the question, "How would you rate your experience with the sedation you have received during surgery?" using a seven-point Likert-like verbal rating scale. Repeated measurements were analyzed by repeated measures ANOVA for HR and BP. Most of our patients were satisfied with their sedation. In most of the patients, MAP and HR dropped after the bolus dose of dexmedetomidine, and the drop was statistically significant. Dexmedetomidine can be used as a sole sedative agent in patients undergoing the liberation procedure

SELECTION OF CITATIONS
SEARCH DETAIL